Generate a tailored SOP for Dr. Daryl Ariawan. Improve your application with a focused, well-structured draft.
Daryl completed a PhD in synthetic organic chemistry at the University of New South Wales, focusing on exploiting the fluorine gauche effect applications in medicinal supramolecular chemistry. Currently, Daryl is affiliated with the Dementia Research Centre at Macquarie University, where he is involved in synthesizing novel peptide sequences as therapeutics for various diseases, particularly dementia and Alzheimer's disease. His research output includes multiple projects aimed at developing small molecule therapeutics to target toxic tau-signaling pathways and advancing gene therapy techniques for neurodegenerative conditions. With a strong publication record, Daryl actively collaborates with other researchers to explore innovative approaches to disease treatment and prevention. His h-index of 108 reflects a significant impact in his field, and he has been recognized for his contributions to advancing knowledge in synthetic organic chemistry and its application in medicine.
Dementia Research Centre • Sydney, Australia
Conducting research on novel peptide sequences as therapeutics for dementia.
Applied to Department of Business (MBA Program).